Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2020-04-29
Product name:
CLINIMIX
Description:
6% AMINO ACIDS (BLEND D) WITHOUT ELECTROLYTES IN 5% DEXTROSE INJECTION
DIN:
02498448
Product Monograph/Veterinary Labelling:
Date:
2022-03-31
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
16
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA10 COMBINATIONS
Active ingredient group (AIG) number:See footnote5
1662220001
Active ingredient(s) See footnote8 | Strength |
---|---|
ALANINE | 1242 MG / 100 ML |
DEXTROSE | 5 G / 100 ML |
GLYCINE | 618 MG / 100 ML |
HISTIDINE | 288 MG / 100 ML |
L-ARGININE | 690 MG / 100 ML |
L-ISOLEUCINE | 360 MG / 100 ML |
L-LEUCINE | 438 MG / 100 ML |
L-LYSINE HYDROCHLORIDE | 348 MG / 100 ML |
L-PHENYLALANINE | 336 MG / 100 ML |
L-PROLINE | 408 MG / 100 ML |
L-THREONINE | 252 MG / 100 ML |
L-TYROSINE | 24 MG / 100 ML |
L-VALINE | 348 MG / 100 ML |
METHIONINE | 240 MG / 100 ML |
SERINE | 300 MG / 100 ML |
TRYPTOPHAN | 108 MG / 100 ML |